Cencora, a global pharmaceutical solutions leader formerly known as AmerisourceBergen, enhances healthcare delivery for people and animals worldwide. Following its acquisition of PharmaLex, Cencora has further strengthened its capabilities in providing comprehensive support to pharmaceutical, biotech, and medtech companies, from clinical development and regulatory strategy through to market access and commercialization. The company connects manufacturers, providers, pharmacies, and patients, ensuring reliable access to therapies and driving innovation across the healthcare ecosystem. Cencora is united in its responsibility to create healthier futures.
The Conshohocken headquarters serves as the central hub for Cencora's global operations, strategic decision-making, corporate functions, and executive leadership, overseeing its diverse pharmaceutical distribution, manufacturer services, animal health, and specialty service businesses, including the integrated PharmaLex solutions.
Located within the SORA West development, the headquarters is a modern, state-of-the-art facility designed to foster collaboration and innovation. It features sustainable design elements, advanced technology infrastructure, and various employee amenities aimed at creating a productive and engaging work environment.
Cencora's headquarters fosters a work culture centered on purpose, innovation, and collaboration. It emphasizes a patient-first approach, diversity and inclusion, and empowers team members to contribute to the company's mission of creating healthier futures. The environment is designed to be dynamic and supportive of professional growth.
The headquarters symbolizes Cencora's evolution and commitment to leadership in the global healthcare sector. Its location provides access to a rich talent pool and facilitates partnerships within the vibrant East Coast life sciences corridor, supporting Cencora's expansive network and service offerings.
Cencora operates an extensive global network spanning the Americas, Europe, Asia, Australia, and Africa. Key functions supported globally include pharmaceutical sourcing and distribution, specialty pharmacy services, global clinical trial logistics (through its World Courier segment), comprehensive manufacturer commercialization solutions (including regulatory, market access, and HEOR services via PharmaLex), animal health products and services, and advanced analytics and technology platforms. This widespread presence allows Cencora to support partners and patients across the entire pharmaceutical lifecycle, ensuring access to care worldwide.
1 West First Avenue
Conshohocken
Pennsylvania
USA
Address: 4 The Heights, Weybridge, Surrey, KT13 0NY, United Kingdom
This office is crucial for Cencora's engagement with European pharmaceutical manufacturers, healthcare providers, and regulatory bodies. It helps tailor Cencora's global solutions to meet the specific needs of the European market and supports international clients navigating the complexities of the region.
Address: [Specific Cencora Tokyo Office Address - e.g., Marunouchi district or similar business hub]
Facilitates Cencora's support for pharmaceutical and biotech companies operating in or entering the Japanese and APAC markets, providing localized expertise and access to Cencora's global network and GxP-compliant solutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, PharmaLex' leadership includes:
PharmaLex has been backed by several prominent investors over the years, including:
Executive team activity at Cencora in the last 12-18 months primarily reflects Cencora's strategic alignment following its rebranding (August 2023) and the integration of significant acquisitions like PharmaLex (completed January 2023). Key existing leaders have taken on expanded or clarified roles to drive synergy and growth. No major unexpected C-suite departures from the core Cencora executive team have been publicly announced recently.
Discover the tools PharmaLex uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Cencora commonly utilizes standardized corporate email formats. The most prevalent patterns involve a combination of the employee's first name and last name, or their first initial and last name, followed by the '@cencora.com' domain. Slight variations might exist across different departments or regions.
first.last@cencora.com or firstinitiallast@cencora.com (e.g., jdoe@cencora.com)
Format
jane.doe@cencora.com
Example
85%
Success rate
Cencora Newsroom • August 30, 2023
AmerisourceBergen officially completed its rebranding to Cencora. This change reflects the company's expanded global reach, its united identity across its diverse service offerings, and its commitment to creating healthier futures by improving access to pharmaceutical care worldwide....more
Cencora Newsroom (formerly AmerisourceBergen) • January 3, 2023
AmerisourceBergen (now Cencora) announced the successful completion of its acquisition of PharmaLex, a leading provider of specialized services for the pharma, biotech, and medtech industries. This acquisition significantly enhances Cencora's global portfolio of solutions for manufacturers, particularly in regulatory affairs, development consulting, and market access....more
Cencora Newsroom • February 6, 2024
Cencora reported robust financial performance for the first quarter of fiscal year 2024, highlighting strong revenue growth driven by broad-based demand across its segments, including pharmaceutical distribution and manufacturer solutions. The results underscored the company's successful integration efforts and continued execution of its strategic priorities....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including PharmaLex, are just a search away.